Company prepares to launch Moxatag(TM), the first and only FDA-approved once-daily amoxicillin, in the first quarter of 2009
GERMANTOWN, Md., Nov. 19 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), today announced it has hired the following key commercial team members:
|SOURCE MiddleBrook Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved